BioSpace News Archive

AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today that it has begun shipping revenue generating validation kits of one of its ophthalmological diagnostic assays.

Transcat, Inc., a leading provider of accredited calibration services, enterprise asset management services, and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has purchased all of the capital stock of privately-held SteriQual, Inc., effective July 12, 2023.

Current Surgical Inc. today announced that it has received a $400,000 grant from the National Institutes of Health (NIH) to support the development of its technology.

DENTSPLY SIRONA Inc. announced that the Company will be hosting an investor conference call and live webcast on Thursday, August 3, 2023, at 8:30 am ET to review its second quarter financial results.

Conference call to be held on Thursday, July 27, 2023, at 8:30 a.m. Eastern Time.

AVROBIO, Inc today announced that it has completed a review of its business, including the status of its programs, resources, and capabilities.

Glaukos Corporation plans to release second quarter 2023 financial results after the market close on Wednesday, August 2, 2023.

BPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare diseases, today announced that it has signed a collaborative agreement with Grupo Terralpe, Inc., a renowned private investment group based in Mexico City and Boston, Mass.

AmplifyBio today announced the successful acquisition of a cutting-edge intellectual property (IP) that, among other capabilities, will allow them to offer non-viral gene-editing services to clients.

Konica Minolta Healthcare Americas, Inc., announced the introduction of PocketPro H2, a new wireless handheld ultrasound device for general imaging in point-of-care applications.